China Blood Collection Devices Market (2025-2030)
The China Blood Collection Devices Market was valued at $266.6 Million in 2025 and projected to reach to $450.5 Million by 2030, representing a compound annual growth rate of 11.1%. China's blood collection devices market is positioned for sustained growth through 2030, with the market expanding from USD 266.6 million in 2025 to USD 450.5 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Blood Collection Devices Market Trends and Insights
- This 11.1% compound annual growth rate significantly outpaces global trends, driven by China's aging population, rising prevalence of chronic diseases, and substantial investments in healthcare infrastructure modernization.
- China's expanding diagnostic and transfusion services, coupled with increasing awareness of bloodborne pathogen safety, are accelerating demand for advanced collection technologies. The Chinese market benefits from government initiatives promoting standardized blood collection protocols and the proliferation of blood banks and diagnostic centers across urban and rural regions.
- China's pharmaceutical and biotechnology sectors are driving innovation in collection device design, including safety-engineered needles and automated collection systems.
- Between 2025 and 2030, China is expected to consolidate its position as a key growth engine within the Asia Pacific region, supported by rising healthcare expenditure and regulatory emphasis on infection prevention standards..
Key Market Statistics
- CAGR (2025-2030) 11.1% CAGR
- Market Size, 2025 ~USD 266.6 Million
- Forecast, 2030 ~USD 450.5 Million
- Country China
China Blood Collection Devices Market Overview
Rapid Market Expansion :
China's blood collection devices market is growing at 11.1% CAGR, significantly outpacing the global rate of 7.4%, driven by increased healthcare spending and modernization initiatives across the country.
Aging Population Dynamics :
China's rapidly aging demographic is driving demand for diagnostic testing and blood collection services, with the elderly population requiring more frequent health screenings and chronic disease management.
Healthcare Infrastructure Investment :
Substantial government investments in healthcare modernization, including rural clinic upgrades and hospital expansions, are expanding access to blood collection services across urban and rural regions.
Chronic Disease Prevalence :
Rising incidence of diabetes, hypertension, and cardiovascular diseases in China is increasing demand for routine blood testing and collection devices in both clinical and point-of-care settings.
China Blood Collection Devices Market Dynamics
- This trajectory reflects structural shifts in healthcare demand driven by demographic aging and disease burden increases.
- Government policies promoting preventive healthcare and diagnostic accessibility are accelerating adoption across tier-2 and tier-3 cities, where healthcare infrastructure development remains a priority. The competitive landscape is intensifying as both domestic manufacturers and international players invest in China's market.
- Innovation in safety-engineered devices, automation-compatible collection systems, and point-of-care solutions are becoming critical differentiators.
- Regulatory harmonization with international standards and increasing hospital standardization protocols are creating opportunities for premium product segments, particularly in urban healthcare facilities..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- China's blood collection devices market is valued at USD 266.6 million in 2025, with a projected value of USD 450.5 million by 2030, representing an 11.1% CAGR.
- China's aging demographic and rising chronic disease burden are primary drivers of increased blood collection and diagnostic testing demand.
- Government healthcare infrastructure investments and standardized blood collection protocols are accelerating market growth across China's urban and rural regions.
- China's emphasis on safety-engineered devices and infection prevention is spurring innovation in collection technology and positioning the country as a regional market leader.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
China Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 97.6 | 106.2 | 114.5 | 123.8 | 134.6 | 146.9 | 160.8 | 176.7 | 9.1 |
| DIAGNOSTIC & PATHOLOGY LABS | 131.6 | 145.2 | 158.7 | 174.1 | 192 | 212.4 | 235.9 | 262.8 | 10.6 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 314.4 | 349.8 | 385.5 | 426.3 | 473.8 | 528.3 | 591 | 663.4 | 11.5 |
| OTHER END USERS | 35.8 | 38.8 | 41.6 | 44.7 | 48.4 | 52.5 | 57.2 | 62.5 | 8.5 |
| TOTAL | 579.5 | 639.9 | 700.2 | 768.9 | 848.8 | 940.1 | 1044.9 | 1165.3 | 10.7 |
Target Audience
- Medical Device Manufacturers : Manufacturers of blood collection devices need China-specific market data to assess market entry feasibility, competitive positioning, and growth potential in this 11.1% CAGR market with expanding healthcare infrastructure.
- Healthcare System Operators : Hospital networks, diagnostic centers, and clinic operators require market insights to optimize procurement strategies, understand demand trends, and plan capital investments in blood collection infrastructure across regions.
- Investment & Private Equity Firms : Investors evaluating healthcare opportunities in China need validated market sizing, growth projections, and competitive landscape analysis to support due diligence and portfolio decision-making in this high-growth segment.
- Healthcare Consultants & Advisors : Strategy consultants supporting healthcare clients in China require detailed market analysis, demographic drivers, and regulatory insights to develop informed go-to-market strategies and business plans.
- Government & Policy Organizations : Healthcare policy makers and government agencies need market intelligence on blood collection device adoption, infrastructure gaps, and industry trends to inform healthcare modernization initiatives and procurement policies.
Key Companies in the China Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for China (USD 266.6M in 2025) and verified 11.1% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to this high-growth market.
- Competitive Positioning Intelligence : Understand China-specific competitive dynamics, local manufacturer capabilities, and international player strategies to identify market entry opportunities, partnership potential, and differentiation strategies in this rapidly consolidating market.
- Demographic & Disease Trend Analysis : Access detailed insights into China's aging population impact, chronic disease prevalence patterns, and regional healthcare disparities to tailor product development, marketing, and distribution strategies effectively.
- Regulatory & Infrastructure Insights : Gain clarity on China's healthcare modernization initiatives, regulatory requirements, hospital standardization protocols, and government healthcare policies that directly influence market opportunities and compliance requirements.
- Regional Expansion Roadmap : Identify high-growth sub-regions and tier-2/tier-3 city opportunities where healthcare infrastructure expansion is accelerating, enabling prioritized market entry and resource allocation strategies for maximum ROI.
Frequently asked questions
What is the current market size of blood collection devices in China?
China's blood collection devices market is valued at USD 266.6 million in 2025 and is projected to grow to USD 450.5 million by 2030.
What is the expected growth rate for China's blood collection devices market?
China's blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 11.1% from 2025 to 2030.
What factors are driving growth in China's blood collection devices market?
Key drivers include China's aging population, rising prevalence of chronic diseases, government healthcare infrastructure investments, and increased emphasis on bloodborne pathogen safety and infection prevention.
How does China's market growth compare to global trends?
China's 11.1% CAGR significantly outpaces the global blood collection devices market CAGR of 7.4%, positioning China as a high-growth market within the Asia Pacific region.
What types of innovations are emerging in China's blood collection devices market?
China's market is seeing increased adoption of safety-engineered needles, automated collection systems, and advanced collection technologies driven by regulatory requirements and healthcare modernization initiatives.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
